Antibiotics at the crossroads.
Nathan
Carl
C
Department of Microbiology & Immunology, Weill Cornell Medical College, and Weill Graduate School of Medical Sciences of Cornell University, 1300 York Avenue, New York 10021, USA.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis* / Q000191:economics* / Q000494:pharmacology; D000995:Antitubercular Agents / Q000191:economics; D019049:Developed Countries / Q000191:economics; D003906:Developing Countries / Q000191:economics; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000191:economics; D004345:Drug Industry / Q000191:economics* / Q000639:trends*; D024881:Drug Resistance, Bacterial; D019649:Food Industry; D006801:Humans; D009939:Organizations, Nonprofit / Q000191:economics / Q000458:organization & administration / Q000639:trends; D010330:Patents as Topic
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents